Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Ado-Trastuzumab Emtansine on Autologous Platelet Kinetics and Function.

JCO precision oncology·2022
Same author

Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.

Transfusion·2020
Same author

The impact of donor sex and age on stored platelet metabolism and post-transfusion recovery.

Blood transfusion = Trasfusione del sangue·2020
Same author

Transfusion-related immunomodulation: gamma irradiation alters the effects of leukoreduction on alloimmunization.

Transfusion·2019
Same author

Pathogen reduction with amotosalen/UVA reduces platelet refractoriness in a dog platelet transfusion model.

Vox sanguinis·2019
Same author

Platelets stored in whole blood at 4°C: in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function.

Transfusion·2019

Related Experiment Video

Updated: Jul 10, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Evidence-based platelet transfusion guidelines.

Sherrill J Slichter1

  • 1Platelet Transfusion Research, Puget Sound Blood Center, 921 Terry Avenue, Seattle, WA 98104-1256, USA. sjslichter@psbc.org

Hematology. American Society of Hematology. Education Program
|November 21, 2007
PubMed
Summary

Platelet transfusions are effective when stored for 5 days. Specific transfusion triggers and leukoreduction strategies improve outcomes, though some benefits remain under investigation. Managing poor responses requires addressing multifactorial causes.

More Related Videos

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Related Experiment Videos

Last Updated: Jul 10, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
10:32

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Area of Science:

  • Transfusion Medicine
  • Hematology

Background:

  • Platelet (plt) products include pooled random-donor and single-donor apheresis platelets.
  • Stored platelet products are equally efficacious up to 5 days.

Purpose of the Study:

  • To review current practices and evidence regarding platelet transfusion efficacy, triggers, and management of poor responses.
  • To highlight the role of leukoreduction and address controversies surrounding its universal application.

Main Methods:

  • Review of existing literature and clinical trial data on platelet transfusion efficacy and triggers.
  • Discussion of factors influencing platelet transfusion response, including alloimmunization and non-immune causes.

Main Results:

  • Prophylactic platelet transfusion triggers of 10,000/microL are hemostatically effective and cost-efficient.
  • Therapeutic transfusion triggers vary by procedure: 100,000/microL for neurosurgery, 50,000-100,000/microL for other invasive procedures/trauma.
  • Leukoreduction reduces alloimmunization, CMV transmission, and febrile reactions; immunomodulatory benefits are debated.

Conclusions:

  • Established transfusion triggers provide hemostatic efficacy.
  • Leukoreduction offers documented benefits, but universal application and immunomodulatory effects require further research.
  • Poor platelet transfusion responses are multifactorial, necessitating tailored management strategies.